Merck, a leading science and technology company, has entered into a partnership with Promega Corporation, a global life ...

Leiden researchers, led by Sebastian Pomplun, have developed a new method to screen hundreds of thousands of molecules for ...

It's the latest stride by Nvidia and the pharmaceutical industry to harness AI to try to reduce costs and shorten the time it ...

Spinal cord injury (SCI) remains a major unmet medical challenge, often resulting in permanent paralysis and disability with ...

Eli Lilly is collaborating with Nvidia to build “the most powerful supercomputer owned and operated by a pharmaceutical company.” The system will power an “AI factory” — a computing infrastructure ...

SandboxAQ, a U.S.-based artificial intelligence and quantum technology firm, signed an agreement with Bahrain's sovereign ...

A technology that combines transcriptomic data and AI enables a novel approach to drug discovery based on the state of cells, ...

DNA-encoded libraries have numerous advantages over traditional screening methods, including easy identification of compounds and the large quantity of compounds that can be screened simultaneously.

Discover how Google's quantum echoes algorithm is solving real-world problems in drug discovery, material science, and ...

ELRIG Drug Discovery 2025 recognizes BubbleFect, a lipid-free cell delivery system that utilizes phase separation peptides ...

Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is most impactful in the drug discovery marketplace: Drug discovery companies ...

The drugmaker hopes an Nvidia-chip powered supercomputer will help it find new drugs and accelerate lengthy R&D timelines.